Cetirizine Hydrochloride

Phase 3Small molecule

GSK

Cetirizine Hydrochloride is one of 46 small molecule programs targeting Fasting Conditions. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Fasting ConditionsCompleted

UrticariaRecruiting

Fasting ConditionsPreclinical

Completed

UrticariaPhase 3

Recruiting

Competition

Competitive Landscape

35 competitors in Fasting Conditions

#DrugCompanyPhaseTrials

Dynastat

Pfizer

Phase 3

1 2

Flomax

Sanofi

Phase 1

2 3

Jardiance

Boehringer Ingelheim

Phase 1

4 4

Cetirizine Hydrochloride

GSK

Phase 3

1 5

Lamisil

Novartis

Preclinical

1 6

Monopril

Bristol-Myers Squibb

Preclinical

1 7

Ambien

PPurdue Pharma LP

Preclinical

4 8

Jardiance

Boehringer Ingelheim

Phase 1

1 9

Anjeso

Boehringer Ingelheim

Preclinical

3 10

Isopto Carpine

AAdvanz Pharma

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Fed2 trials

Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition

Completed·—·Phase 1·NCT01064115·30 enrolled

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions

Completed·RRanbaxy Laboratories Limited·N/A·NCT00776022·32 enrolled

MRI Scan1 trial

A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.

Completed· GSK logo

GSK··NCT00517946·21 enrolled

Neuropathic Pain1 trial

Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.

Completed·NNatalia Valadares de Moraes·Phase 4·NCT03047278·29 enrolled

Urticaria1 trial

Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria

Recruiting·SShandong New Time Pharmaceutical Co., LTD·Phase 3·NCT06819774·284 enrolled

Fasting Conditions1 trial

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions

Completed·RRanbaxy Laboratories Limited·N/A·NCT00776139·32 enrolled

2 more indications

Pelvic Pain1 trial

Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction

Completed·NNorthwestern University·Phase 1·NCT03167216·20 enrolled

Unspecified1 trial

Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition

Completed·—·Phase 1·NCT01064102·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for Cetirizine Hydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Cetirizine Hydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Cetirizine Hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: GSK

Cetirizine Hydrochloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Fed2 trials

MRI Scan1 trial

Neuropathic Pain1 trial

Urticaria1 trial

Fasting Conditions1 trial

Pelvic Pain1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News